Verastem | VSTM - Market Capitalization

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $164.9M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Curis USD 3M 10M Apr/2026
Cytokinetics USD 7.77B 1.19B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Verastem USD 134M 462M Apr/2026